Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
1986 1
2017 1
2018 2
2019 3
2020 4
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, Heil J, Riedel F, de Boniface J, Andre C, Matrai Z, Pukancsik D, Paulinelli RR, Ostapenko V, Burneckis A, Ostapenko A, Ostapenko E, Meani F, Harder Y, Bonollo M, Alberti ASM, Tausch C, Papassotiropoulos B, Helfgott R, Heck D, Fehrer HJ, Acko M, Schrenk P, Trapp E, Gunda P, Clara P, Montagna G, Ritter M, Blohmer JU, Steffen S, Romics L, Morrow E, Lorenz K, Fehr M, Weber WP. Fitzal F, et al. Among authors: helfgott r. Ann Surg Oncol. 2022 Feb;29(2):1073-1075. doi: 10.1245/s10434-021-10898-y. Ann Surg Oncol. 2022. PMID: 34676460 No abstract available.
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
Fitzal F, Bolliger M, Dunkler D, Geroldinger A, Gambone L, Heil J, Riedel F, de Boniface J, Andre C, Matrai Z, Pukancsik D, Paulinelli RR, Ostapenko V, Burneckis A, Ostapenko A, Ostapenko E, Meani F, Harder Y, Bonollo M, Alberti ASM, Tausch C, Papassotiropoulos B, Helfgott R, Heck D, Fehrer HJ, Acko M, Schrenk P, Trapp EK, Gunda PT, Clara P, Montagna G, Ritter M, Blohmer JU, Steffen S, Romics L, Morrow E, Lorenz K, Fehr M, Weber WP. Fitzal F, et al. Among authors: helfgott r. Ann Surg Oncol. 2022 Feb;29(2):1061-1070. doi: 10.1245/s10434-021-10809-1. Epub 2021 Oct 13. Ann Surg Oncol. 2022. PMID: 34647202 Free PMC article.
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.
Steger GG, Egle D, Bartsch R, Pfeiler G, Petru E, Greil R, Helfgott R, Marth C, Öhler L, Hubalek M, Lang A, Tinchon C, Haslbauer F, Redl A, Hock K, Hennebelle M, Mraz B, Gnant M. Steger GG, et al. Among authors: helfgott r. Breast. 2020 Apr;50:64-70. doi: 10.1016/j.breast.2020.01.035. Epub 2020 Jan 31. Breast. 2020. PMID: 32062536 Free PMC article.
Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients.
Hammer J, Geinitz H, Nieder C, Track C, Thames HD, Seewald DH, Petzer AL, Helfgott R, Spiegl KJ, Heck D, Bräutigam E. Hammer J, et al. Among authors: helfgott r. Clin Breast Cancer. 2019 Feb;19(1):58-62. doi: 10.1016/j.clbc.2018.08.001. Epub 2018 Aug 22. Clin Breast Cancer. 2019. PMID: 30197244 Clinical Trial.
Vertebral abnormalities associated with synthetic retinoid use.
Gerber LH, Helfgott RK, Gross EG, Hicks JE, Ellenberg SS, Peck GL. Gerber LH, et al. Among authors: helfgott rk. J Am Acad Dermatol. 1984 May;10(5 Pt 1):817-23. doi: 10.1016/s0190-9622(84)70097-1. J Am Acad Dermatol. 1984. PMID: 6586753
13 results